NeuroSigma, Inc.

NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients` lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), covering a wide-spectrum of disorders, including ADHD.